Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Armando Anido

Recent news which mentions Armando Anido

Zynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The Details
Tickers ZYNE
Tags ZYNE premium Earnings
From Benzinga
Zynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss?
Tickers ZYNE
Tags Armando Anido Benzinga Market News
From Benzinga
What's The Role Of The Endocannabinoid System In Fragile X Syndrome? How Can Cannabidiol Treatment Help? New Paper
Tickers ZYNE
Tags Benzinga Market News Armando Anido
From Benzinga
Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy
Tickers INNO
Tags Kevin Heyeck John Crawley Vincent Milano
From Business Journals
CBD-Based Zygel Helps With Anxiety-Related & Behavioral Symptoms In 22q11.2 Deletion Syndrome, Phase 2 Trial Reveals
Tickers ZYNE
Tags ZYNE premium Markets
From Benzinga
Zynerba Pharmaceuticals R&D Expanses For Q2 Reach 5.4M, Here Are The Details
Tickers ZYNE
Tags Armando Anido Benzinga Market News
From Benzinga
Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details
Tickers CCORF ZYNE
Tags CCORF Earnings Ladenburg Thalmann & Co/ Inc/
From Benzinga
Zynerba Pharmaceuticals Reveals Lower Net Loss For Q4 And Full Year 2021
Tickers ZYNE
Tags Benzinga Market News Armando Anido
From Benzinga
Zynerba Pharmaceuticals Completes Enrollment For CBD Transdermal Trial For 22q Deletion Syndrome
Tickers ZYNE
Tags News Markets ZYNE
From Benzinga
Cannabis Movers & Shakers: Cresco, Agricor & Botanacor, C3 Industries, Akanda, CULTA, OWP, Zynerba
Tickers AYRWF CRLBF HOG LAD
Tags Benzinga appointments Markets
From Benzinga
Zynerba Pharmaceuticals Names New CLO & Corporate Secretary
Tags Suzanne Hanlon executives Movers & Shakers
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.